Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

64.80 -1.88 (-2.82%)
Delayed Quote Updated: 10:17 AM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
CareDx President and CEO Sells 19,000 Shares for $412,000 ↗
This transplant diagnostics specialist saw a notable insider sale amid a year of modest share price decline and ongoing product innovation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Analysts Have This To Say About CareDx ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
4 Analysts Assess CareDx: What You Need To Know ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 30, 2025 ↗
 
Via Benzinga
News headline image
Where CareDx Stands With Analysts ↗
 
Via Benzinga
News headline image
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential ↗
CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market. 
Via Benzinga
News headline image
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
CareDx (CDNA) EPS Beats Sales Gain 14% ↗
Via The Motley Fool
News headline image
CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth ↗
CareDx Inc (CDNA) reported mixed Q2 2025 results with revenue of $86.7M, missing estimates, but adjusted revenue rose 14% YoY. Testing volumes grew 13%, while shares fell 6.8% post-earnings. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 26, 2025 ↗
 
Via Benzinga
News headline image
Breaking Down CareDx: 3 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
A Closer Look at 5 Analyst Recommendations For CareDx ↗
 
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Gapping stocks in Thursday's session ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Analyst Expectations For CareDx's Future ↗
 
Via Benzinga
News headline image
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta ↗
Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx. 
Via Benzinga
News headline image
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 ↗
Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared? ↗
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review ↗
A Fed rate cut and a slew of big earnings reports filled out a busy week. 
Via Investor's Business Daily
Topics Economy Government
News headline image
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
Via Benzinga
Topics ETFs Stocks
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.